Concept
Association study between continued use of RAS inhibitors with clinical outcome
- study sample consisted of 614 hypertensive COVID-19 patients during hospitalization
- demographics, comorbidities, vital signs, lab data, and ACEi/ARB usage were analyzed
- mortality and ICU rates were not significantly different between RAS inhibitor users and non-users
- patients who continued ACEi/ARBs in hospital had lower ICU admission and mortality rates
0
1
Updated 2021-02-28
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Association study between the use of RAS inhibitors with mortality among patients with hypertension hospitalized with COVID-19
Observational study of hypertension and antihypertensive treatment with COVID-19 mortality
Association study between continued use of RAS inhibitors with clinical outcome
RAS inhibitors improve clinical outcomes of COVID-19 patients with hypertension